eniluracil has been researched along with Neoplasms, Squamous Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Browman, G; Clarke, R; Cooke, A; Cripps, C; Goss, G; Khoo, K; Klaassen, D; Knowling, M; Matthews, S; Seymour, L; Siu, L; Tannock, I | 1 |
1 trial(s) available for eniluracil and Neoplasms, Squamous Cell
Article | Year |
---|---|
A National Cancer Institute of Canada clinical trials group phase II study of eniluracil (776C85) and oral 5-fluorouracil in patients with advanced squamous cell head and neck cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Canada; Enzyme Inhibitors; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Squamous Cell; Treatment Outcome; Uracil | 2001 |